Phase 3 Amblyopia Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
Amblyopia
Jaeb Center for Health Research544 enrolled68 locationsNCT04378790
Recruiting
Phase 3
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Amblyopia
Jaeb Center for Health Research252 enrolled58 locationsNCT06524882
Recruiting
Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
Amblyopia
Jaeb Center for Health Research238 enrolled73 locationsNCT06380517